←
MultiPark at LundU1,139 posts
MultiPark at LundU avatar

MultiPark at LundU

@MultiparkL

MultiPark is a translational programme ranging from experimental pre-clinical research to studies on the life situation of patients with #neurodegeneration.

◷ Joined May 2020▧ 405 Photos and videos
MultiPark at LundU avatar
MultiPark at LundU@MultiparkL·18 Feb 2025

Important Update from MultiPark! We want to inform you that MultiPark will no longer be active at X. You can continue to follow our latest research, news, and updates on LinkedIn 👉 linkedin.com/company/multipa… Thank you for your support, and we look forward to staying in touch!

BioFINDER avatar
⟳ MultiPark at LundU retweeted
BioFINDER@biofinder_study·20 Jan 2025

A new The Swedish BioFINDER study paper in collaboration with WRAP has been published in @Brain1878 ! academic.oup.com/brain/advan… Find our key findings 👇

MultiPark at LundU avatar
MultiPark at LundU@MultiparkL·20 Jan 2025

"In this study we identify the glymphatic system as a new mechanism contributing to the well-established link between cardiovascular pathologies and neurodegeneration" says Marios Kritsilis, lead author of the project. Read more about their findings 👉 doi.org/10.1093/brain/awae41…

MultiPark at LundU avatar
MultiPark at LundU@MultiparkL·20 Jan 2025

The glymphatic system, specialized in clearing waste from the brain, is linked to various neurodegenerative diseases. However, the impact of heart failure on the glymphatic system's function remains poorly understood.

Post attachment
Patrik Brundin MD PhD avatar
⟳ MultiPark at LundU retweeted
Patrik Brundin MD PhD@BrundinPatrik·8 Jan 2025

Great review on #stemcell therapies from @Kirkeby_Lab who is affiliated with @Lund_Stem and @MultiparkL at @medfak_LU @lunduniversity

Since the derivation of hPSCs, technologies to control their differentiation and manufacturing have advanced immensely, enabling increasing numbers of clinical trials with #hPSC-derived products. 🔎 Learn more in this @CellStemCell review. bit.ly/41ZMTp5

Post attachment
MultiPark at LundU avatar
MultiPark at LundU@MultiparkL·3 Jan 2025

This work highlights both the potential and the challenges of using DTI in glymphatic research, paving the way for improved techniques to study brain health. Read more about their findings here 👉 doi.org/10.1093/braincomms/f… Lead author: Charalampos Georgiopoulos

MultiPark at LundU avatar
MultiPark at LundU@MultiparkL·3 Jan 2025

However, a known limitation of DTI arises when nerve fibers cross—an issue affecting about 90% of the brain's white matter. In their study, the researchers demonstrated how fiber crossing impacts DTI measurements of the perivascular space and the assessment of glymphatic flow.

MultiPark at LundU avatar
MultiPark at LundU@MultiparkL·3 Jan 2025

@m_nilsson and collaborators investigated the potential of diffusion tensor imaging (DTI), a non-invasive MRI technique, to study glymphatic flow. DTI maps the movement of water molecules in the brain, making it a powerful tool for tracking nerve pathways.

MultiPark at LundU avatar
MultiPark at LundU@MultiparkL·3 Jan 2025

However, one of the key challenges in understanding the glymphatic system lies in accurately visualizing and assessing glymphatic flow.

MultiPark at LundU avatar
MultiPark at LundU@MultiparkL·3 Jan 2025

The glymphatic system, a specialized waste-clearing network in the brain, plays a role similar to the lymphatic system in the rest of the body. Changes in this crucial system have been linked to neurodegenerative diseases such as Parkinson's and Alzheimer's.

Post attachment
Daniella Rylander Ottosson avatar
⟳ MultiPark at LundU retweeted
Daniella Rylander Ottosson@Ottossonlab·23 Dec 2024

Happy and honoured to have been awarded a STIAS: Stellenbosch Institute for Advanced Study fellowship for 2025! Look forward to spend the autumn in South Africa 🇿🇦! stias.ac.za/fellows/daniella… @lunduniversity @MultiparkL @Lund_Stem @medfak_LU @Ottossonlab

MultiPark at LundU avatar
MultiPark at LundU@MultiparkL·11 Dec 2024

Recent research highlights corticotropin-releasing hormone (CRH) as a promising biomarker candidate for PS. @OskarHansson9 and collaborators investigated this link, read about their results here 👉 doi.org/10.1093/braincomms/f… Lead authors: @atulkumar1301 and Bárbara Fernandes Gomes

MultiPark at LundU avatar
MultiPark at LundU@MultiparkL·11 Dec 2024

Biomarkers have transformed Alzheimer's disease diagnosis, and a similar breakthrough is needed for Parkinson's disease and related disorders, known as Parkinsonian syndromes (PS).

Post attachment